1810013L24Rik Inhibitors
1810013L24Rik Inhibitors encompass a group of small molecules that can modulate the activity or function of the protein 1810013L24Rik through various indirect methods. There may not be well-established or specific inhibitors designed for direct targeting of 1810013L24Rik. Therefore, researchers have explored alternative strategies to influence this protein's function and its associated cellular processes.
One approach within this class involves utilizing small molecule agonists that can activate upstream signaling pathways or receptors, indirectly impacting the activity of 1810013L24Rik. Additionally, researchers can employ RNA interference (RNAi) techniques, such as small interfering RNAs (siRNAs) or short hairpin RNAs (shRNAs), to knock down the expression of genes or proteins that interact with 1810013L24Rik. Another avenue is the use of proteasome inhibitors like Bortezomib, which indirectly affect protein turnover and may influence cellular pathways involving 1810013L24Rik. Furthermore, histone deacetylase inhibitors (HDACis) such as Trichostatin A can modify chromatin structure through histone acetylation, potentially altering gene expression patterns associated with 1810013L24Rik. DNA methylation inhibitors like 5-Azacytidine can also induce changes in DNA methylation patterns, indirectly affecting genes and pathways related to 1810013L24Rik.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits the mammalian target of rapamycin (mTOR), a central regulator of cell growth, proliferation, and protein synthesis. It does so by forming a complex with FKBP12, leading to the inhibition of mTOR signaling pathways that drive various cellular processes. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is a potent phosphoinositide 3-kinase (PI3K) inhibitor that disrupts cell growth and survival signaling pathways by covalently binding to the PI3K enzyme, thus inhibiting its activity and downstream signaling. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine is a broad-spectrum inhibitor of protein kinases. It targets a wide range of serine/threonine kinases, impacting multiple signaling cascades involved in cell regulation and signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3K inhibitor that interferes with PI3K-mediated signaling pathways. It can affect cell survival, growth, and proliferation by disrupting PI3K-related processes. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 is a specific inhibitor of p38 mitogen-activated protein kinase (MAPK), which plays a crucial role in stress responses. This compound interferes with p38 MAPK signaling pathways, potentially influencing downstream events. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 inhibits MEK (Mitogen-Activated Protein Kinase Kinase), a key upstream regulator of the extracellular signal-regulated kinase (ERK) pathway in the MAPK cascade. It modulates signaling events related to cell proliferation and differentiation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits c-Jun N-terminal Kinase (JNK), impacting cellular processes such as apoptosis, inflammation, and cellular differentiation. It can indirectly influence signaling pathways related to 1810013L24Rik. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine acts on DNA methylation, leading to DNA hypomethylation and altered gene expression patterns. This epigenetic modulation can affect genes and pathways related to 1810013L24Rik. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor (HDACi) that affects chromatin structure by increasing histone acetylation. This epigenetic modification can influence gene expression and cellular processes associated with 1810013L24Rik. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $92.00 $204.00 | 19 | |
Cyclopamine inhibits the Hedgehog signaling pathway by targeting the smoothened receptor. Disrupting this pathway can influence developmental and cell differentiation processes related to 1810013L24Rik. | ||||||